All results
5 results for tests
-
Adaptive COVID-19 Treatment Trial (ACTT)
This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized…
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
This study builds on the results of several prior studies that we have been involved with to test the hypothesis that Risk-Adapted De-Intensification of…
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
DOTS (20-0002)
This is a Phase 2b clinical study, multicenter, randomized, open-label, assessor-blinded, superiority study. The study will compare dalbavancin to standard of…
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
Sapphire
This study aims to evaluate the efficacy and safety of inhaled treprostinil in subjects with sarcoidosis-associated interstitial lung disease and pulmonary…
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
Oral IRAK-4 inhibitor CA-4948 in combination with Pembrolizumab following stereotactic radiosurgery
This phase I/II trial will investigate the use of the novel oral IRAK-4 inhibitor CA-4948 in combination with pembrolizumab therapy following stereotactic…
- Ages
- 18 Years - 99 Years
- Sexes
- All